Persistent Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2019-02-15
Clinical Trial Update: Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating romiplostim for persistent thrombocytopenia in patients who have received an allogeneic hematopoietic …